Supplementary files for- Immune-mediated hepatic disorders associated with tyrosine kinase inhibitors plus immunotherapy in renal cell carcinoma

Published: 3 January 2023| Version 1 | DOI: 10.17632/pdv4zxr5yn.1
Contributors:
,

Description

Supplementary file S1: Raw data of immune-mediated hepatic disorders associated with TKI plus IC combination therapy. Supplementary file S2: Raw data of drug-drug interactions analysis between TKI and ICI combination therapy.

Files

Steps to reproduce

Those supplementary file S1 and S2 are curated by raw data downloaded from Openvigil (accessed on 13th, November, 2022), a validated online tool to visit cleaned FAERS data. The URL of openvigil is https://openvigil.sourceforge.net/

Institutions

Second Xiangya Hospital

Categories

Medicine

Funding

National Natural Science Foundation of China

82274033

License